APTI ijopp - Indian Journal of Pharmacy Practice

Indian J. Pharm. Pract. 1(2), Jan-Mar, 2009Figure 2: Receiver Operator Curve (ROC) for CD4 ValuesReceiver Operator Curve (ROC) for CD4 Values1Sensitivity0.80.60.40.2CD4= 400CD4= 350CD4= 300CD4= 250CD4= 20000 0.1 0.2 0.3 0.4 0.51- SpecificityReferences1. Fletcher V, Kakuda NK, Collier AC. Human Mehta K, Solomon S. et.al. Changes in Totalimmunodeficiency virus infection. In: Dipiro TJ, Lymphocyte Count (TLC) as a surrogate for changesTallbert LR , Yee CG, Matzke RG, Wells GB, Poseyin CD4 count following initiation of HAART:LM, editors. Pharmacotherapy: A Pathophysiolo-Implications for monitoring in resource – limitedthgical approach. 5 ed. United States of America:settings. J Acquir Immune Defic Syndr 2004; 36:McGraw-Hill Medical publishing division; 2002:567-575.2151-2174.2. Kojic EM, Carpenter CJ. Initiating antiretroviral9. National AIDS control organization (India)therapy. Available from University of California, HIV/AIDS epidemiological surveillance &San Francisco, CA, (US); hivinsite; 2006.estimation report. New Delhi:20053. U.S Food and drug administration (US).FDA 10. World Bank (US).World development indicators,approves the First Once-a-Day Three-Drug India- data and statistics. Washington: DataCombination Tablet for Treatment of HIV-1. Silver profile; 2008Spring: FDA news;2006.11. Reserve bank of India (India).RBI reference rate on4. New York State Department of health (US). Anti-31/07/08.Mumbai:Exchange rate; 2008retroviral therapy. New York :2008.12. World heath organization (Switzerland).Selected5. Guidelines for the Use of Antiretroviral Agents innational health accounts indicators. Geneva: TheHIV-1-Infected Adults and Adolescents. NationalInstitute of Health, Maryland, (US); aidsinfo; world health report; 2006.October 10, 2006.13. World heath organization (Switzerland).Scaling up6. Jacobson MA, Liu L, Bashi HK , Deeks S, Hecht of Antiretroviral Therapy in resource limited setting.FM, Kahn J. Absolute or total lymphocyte count as a Geneva: Guidelines for a public healthmarker for the CD4 T lymphocyte criterion for approach;2002initiating antiretroviral therapy. AIDS 2003;17: 917- 14. Akinola N O, Olasode O, Adediran I. A, Onayemi O,919. Murainah A, Irinoye O. et.al. The Search for a7. Spacek LA, Griswold M, Quinn TC, Moore RD.Predictor of CD4 Cell Count Continues: TotalTotal lymphocyte count and hemoglobin combinedLymphocyte Count Is Not a Substitute for CD4 Cellin an algorithm to initiate the use of highly activeantiretroviral therapy in resource-limited settings.Count in the Management of HIV-InfectedAIDS 2003; 17:1311–1317.Individuals in a Resource-Limited Setting. Clin8. Mahajan AP, Hogan JW, Snyder B, Kumarasamy N, Infec Diseases. 2004; 39:579–581.34